New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
Go back to New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection| (NASDAQ: PSNL) | Delayed: 10.17 -0.37 (3.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.54 | 52 Week High | $ | |||
| Open | $10.49 | 52 Week Low | $ | |||
| Day High | $10.86 | P/E | N/A | |||
| Day Low | $9.65 | EPS | $ | |||
| Volume | 2,506,299 | |||||
